Showing results (311-320 of 1,584) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|October 30, 2024
Low-Dose Naltrexone Use in Biopsy-Proven Lichen Planus of the NailsEric R Bray, Brian W Morrison
JAMA Dermatology|November 13, 2024
Wound Characteristics Among Patients Exposed to XylazineLydia Lutz, Rachel McFadden, Lin Xu, et al.
JAMA Dermatology|November 27, 2024
Merkel Cell Carcinoma and Immunosuppression, UV Radiation, and Merkel Cell PolyomavirusJacob T Tribble, Ruth M Pfeiffer, Isaac Brownell, et al.
JAMA Dermatology|March 6, 2025
Area Deprivation Index and Melanoma Thickness in VeteransAlejandra K Moncayo, Jacqueline M Ferguson, Mathew P Dizon, et al.
JAMA Dermatology|March 6, 2025
Human Papillomavirus Vaccination and Actinic Keratosis Burden: The VAXAK Randomized Clinical TrialEmily Wenande, Anna Hastrup, Stine Wiegell, et al.
JAMA Dermatology|March 12, 2025
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet SyndromeChloé Grolleau, Maxime Battistella, Eve Zakine, et al.
JAMA Dermatology|October 9, 2024
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic DiseaseValdemar Wendelboe Nielsen, Oliver Bundgaard Vad, Nikolaj Holgersen, et al.
JAMA Dermatology|September 11, 2024
Consensus on a Patient-Centered Definition of Atopic Dermatitis FlareAaron M Drucker, Isabelle J C Thibau, Bryan Mantell, et al.
JAMA Dermatology|July 31, 2024
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical TrialKilian Eyerich, Khusru Asadullah, Andreas Pinter, et al.
JAMA Dermatology|July 17, 2024
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for DiscontinuationReineke Soegiharto, Mehran Alizadeh Aghdam, Jennifer Astrup Sørensen, et al.
Pageof 159